Tuesday, October 18, 2022 6:47:33 PM
And LP holds 139 million NWBO shares or equivalents and knows she can't sell without cratering NWBO stock further.
Frank X has made a lot of money for shareholders -- I was in at ~$15 and sold at close to $200, And a lot of shareholders have profited. But like all of biotech it was crushed int he last year. And more importantly he has successfully led the company to get three U.S. approvals and approvals in many other countries.
But NWBO has lost ~40% even while reporting a significant Phase 3 trial which many on this board claims is a "successful" trial -- but the investment community clearly didn't agree as share price showed no positive response. And this is after 20+ years of burning shareholders cash (~$ Billion plus) and having NO approvals or revenue to show for it.
Frank X has made a lot of money for shareholders -- I was in at ~$15 and sold at close to $200, And a lot of shareholders have profited. But like all of biotech it was crushed int he last year. And more importantly he has successfully led the company to get three U.S. approvals and approvals in many other countries.
But NWBO has lost ~40% even while reporting a significant Phase 3 trial which many on this board claims is a "successful" trial -- but the investment community clearly didn't agree as share price showed no positive response. And this is after 20+ years of burning shareholders cash (~$ Billion plus) and having NO approvals or revenue to show for it.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
